Female Genital Schistosomiasis

N Engl J Med. 2019 Dec 26;381(26):2493-2495. doi: 10.1056/NEJMp1914709.

Authors

Peter J Hotez¹, Dirk Engels¹, Margaret Gyapong¹, Camilla Ducker¹, Mwelecele N Malecela¹

Affiliation

¹ From the National School of Tropical Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston (P.J.H.); Uniting to Combat NTDs (D.E.) and the Schistosomiasis Control Initiative (C.D.) - both in London; the University of Health and Allied Sciences, Ho, Ghana (M.G.); and the World Health Organization, Geneva (M.N.M.).

PMID: 31881137
DOI: 10.1056/NEJMp1914709

No abstract available

MeSH terms

Africa, Southern
Animals
Female
Genital Diseases, Female / parasitology*
HIV Infections / prevention & control
Humans
Life Cycle Stages
Praziquantel / therapeutic use*
Reproductive Health*
Schistosoma haematobium / growth & development*
Schistosomiasis haematobia* / complications
Schistosomiasis haematobia* / drug therapy
Schistosomiasis haematobia* / transmission
Schistosomicides / therapeutic use*
Sexually Transmitted Diseases

Substances

Schistosomicides
Praziquantel

Grants and funding

001/WHO_/World Health Organization/International